ACKR3 and hepatocellular carcinoma: utilized bioinformatics and network pharmacology to identify that the regulator of cell cycle gene (RGCC) and atypical chemokine receptor 3 (ACKR3) are implicated in the progression from non-alcoholic liver disease to hepatocellular carcinoma and impact the prognosis of hepatocellular carcinoma.